Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap)
Abstract Ischemic retinal dystrophies are leading causes of acquired vision loss. Although the dysregulated expression of the hypoxia-responsive VEGF-A is a major driver of ischemic retinopathies, implication of additional VEGF-family members in their pathogenesis has led to the development of multi...
Guardado en:
Autores principales: | Jesús Eduardo Rojo Arias, József Jászai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6774ec12cbe6423b8646f647eb2f6254 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vivo characterization of ischemic retina in diabetic retinopathy
por: Lukas Reznicek, et al.
Publicado: (2010) -
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
por: Stewart MW
Publicado: (2012) -
EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
por: M. M. Bikbov, et al.
Publicado: (2016) -
PGC-1α determines light damage susceptibility of the murine retina.
por: Anna Egger, et al.
Publicado: (2012) -
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
por: Florence T H Wu, et al.
Publicado: (2009)